INTRODUCTION AND OBJECTIVES:
To examine postoperative complications in a contemporary series of patients after radical cystectomy (RC) using the comprehensive complication index (CoCI), a new extension of the Clavien-Dindo-Classification (CDC), that integrates not only the most severe but all events with their respective severity.
METHODS: Using the CoCI, we assessed the 90-day postoperative clinical course of 804 bladder cancer patients who underwent open RC and urinary diversion (ileal conduit n ¼ 510, ileal neobladder n ¼ 294) between June 2003 and December 2015 at a single institution. All Martin criteria for standardized reporting of complications were met. The CoCI is calculated as the sum of all CDC events that are weighted for their severity. The final formula yields a continuous scale to rank the severity of any combination of complications from 0 to 100 in a single patient. Cut-off of the CoCI was set at 26.2%, the equivalent of a single CDC IIIa complication, to assess major complications. Uni-and multivariable analyses for prediction of complications were carried out; covariables included body mass index, Charlson Comorbidity Index (CCI), age, sex, American Society of Anesthesiologists Score (ASA), neoadjuvant chemotherapy, prior abdominal or pelvic surgery, clinically localized tumor and urinary diversion type.
RESULTS: The 90-day rates for overall (CDC I-V) and highgrade complications (CDC III-V), as well as mortality (CDC V), were 58.8, 21.8 and 3.7%, respectively. The median CoCI was 20.9 (IQR 0-29.6) with a CoCI26.2 in 29.2% of the study population. Patients that received an ileal neobladder had a significantly lower CoCI, 8.7% (IQR 0-22.6), compared to those that received ileal conduit, 20.9% (IQR 0-33.7, P¼0.013). Independent risk factors for overall complications were BMI30 (OR 1.75), female gender (OR 1.66) and ASA3 (OR 1.47). Risk factors for a CoCI26.2 were BMI30 (OR 1.52), CCI3 (OR 1.63) and ASA3 (OR 1.72, all P<0.05).
CONCLUSIONS: RC is associated with significant morbidity; nevertheless, the majority of complications are minor. CCI, ASA and BMI might help to identify patients at risk for major complications after radical cystectomy. The comprehensive complication index gives detailed and acurate information on the individual burden of complications. Patients with a history of prior abdominal/pelvic radiation (RT) are thought to be at increased risk for post-operative complications and adverse pathology with RC. Hence, RC may be underutilized in this population. Our objective was to compare post-operative complication rates and pathologic outcomes after RC in patients with prior abdominal/pelvic RT versus those without a RT history.
Source of
METHODS: An IRB approved retrospective cohort study for patients who underwent RC for urothelial carcinoma (UC) at our institution between 2008-2016 was performed. The cohorts included: any prior abdominal/pelvic RT and no prior RT. Outcomes assessed between cohorts included diversion type, final pathology, length of surgery (ORT) and hospital stay (LOS), blood loss (EBL) and post-operative recovery and complications.
RESULTS: We identified 519 patients who underwent RC for UC during the time period studied. Of these, 56 (11%) patients had a history of abdominal/pelvic RT. All previously radiated patients had received RT for pelvic malignancy, most commonly for prostate cancer (60%). When stratified by prior RT, there were no significant differences in EBL, intra-operative transfusion, and time to bowel function. The overall complication rate in RT patients versus those without prior RT was 48% and 52% respectively (p ¼ 0.74). While there was no statistical difference in fascial dehiscence rate (p ¼ 0.075), there did appear to be a clinically significant difference in rate (25% in those with RT versus 9% in those without RT. Comparisons of pathologic features demonstrated no significant difference between the groups for histology, metastases, margin status, cancer specific and overall survival. However, a significant difference in T-classification was observed, with RT patients being more likely to have pT4 disease (p¼0.04).
CONCLUSIONS: Although RC remains a surgical procedure with high complication rates, patients with a history of prior abdominal/ pelvic RT do not appear to have a higher complication rate and should not be excluded from RC on the basis of prior RT alone. Despite the fact that radiated patients are at greater risk for higher pathologic stage, there were no detectable differences in cancer specific and overall survival. Additional prospective studies are needed to better evaluate this cohort of patients to inform treatment decisions.
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MP54-03 BENEFITS AND COMPLICATIONS DURING INPATIENT FOLLOW-UP TREATMENT AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER
Gerald Schulz*, Tobias Grimm, Alexander Buchner, Friedrich Jokisch, Markus Grabbert, Birte-Swantje Schneevoigt, Alexander Kretschmer, Christian Stief, Alexander Karl, 81377 Munich, Germany INTRODUCTION AND OBJECTIVES: A three-week inpatient follow-up treatment (FT) in government-approved rehabilitation clinics is offered after radical cystectomy (RC) for bladder cancer (BC) for all patients in Germany. We investigated both the physical condition and expectations of the patients at the beginning of the FT as well as complications during the 3-week period and results thereafter. METHODS: 81 patients from different urological departments who underwent RC for BC and an orthotopic neobladder reconstruction were included. Time from hospital discharge until beginning of FT, BMI, initial blood count, Karnovsky scale, antibiotics, antithrombotics and use of incontinence pads were assessed. Furthermore patients were asked for main complaints as well as expectations towards the three-week FT. Complications like metabolic acidosis and urinary tract infections during FT as well as medication, incontinence pad use and patients' complaints after FT were monitored. RESULTS: Median time between RC and discharge from the primary hospital to FT was 35 days (interquartile range [IQR] 25-41 days) and 13 days ([IQR] 4-16 days) respectively. The medical condition at the beginning of FT was good: mean Karnovsky 72% ([IQR] 70-88%), mean BMI 23.1 ([IQR] 20.9-27.7), mean hemoglobin, creatinine and leukocytes in the normal range. The five most common complaints mentioned are general weakness (79%), incontinence (77%), pain (31%), fatigue (30%), and mental distress (43%). The three most important expectations towards FT were improvement of the general e722 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 
